A Study of [14C]GB491 in Male Healthy Subjects

Clinical trial NCT05860582 · COMPLETED

Trial details

NCT number: NCT05860582
Sponsor: Genor Biopharma Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Nonsmall Cell Lung Cancer

Start date: 2022-09-14
Primary completion: 2022-11-14
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.